Share on StockTwits

MELA Sciences (NASDAQ:MELA) Director Anthony J. Dimun purchased 87,500 shares of the stock in a transaction that occurred on Thursday, May 22nd. The shares were purchased at an average cost of $0.38 per share, for a total transaction of $33,250.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

MELA Sciences (NASDAQ:MELA) opened at 0.3895 on Wednesday. MELA Sciences has a 52-week low of $0.36 and a 52-week high of $1.20. The stock’s 50-day moving average is $0.49 and its 200-day moving average is $0.63. The company’s market cap is $20.3 million.

MELA Sciences (NASDAQ:MELA) last posted its quarterly earnings results on Tuesday, May 13th. The company reported ($0.16) earnings per share for the quarter.

MELA Sciences, Inc, formerly Electro-Optical Sciences, Inc, is a medical device company focused on the design, development and commercialization of a non-invasive, point-of-care (NASDAQ:MELA) instrument to assist in the early diagnosis of melanoma.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.